BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22911697)

  • 1. Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults.
    Mocroft A; Neuhaus J; Peters L; Ryom L; Bickel M; Grint D; Koirala J; Szymczak A; Lundgren J; Ross MJ; Wyatt CM; ;
    PLoS One; 2012; 7(7):e40245. PubMed ID: 22911697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.
    Peters L; Grint D; Lundgren JD; Rockstroh JK; Soriano V; Reiss P; Grzeszczuk A; Sambatakou H; Mocroft A; Kirk O;
    AIDS; 2012 Sep; 26(15):1917-26. PubMed ID: 22781222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of hepatic and kidney dysfunction among newly diagnosed HIV patients with viral hepatitis infection in Cape Coast, Ghana.
    Anabire NG; Tetteh WJ; Obiri-Yaboah D; Annan I; Luuse AT; Aryee PA; Helegbe GK; Hagan OCK; Eliason S
    BMC Res Notes; 2019 Jul; 12(1):466. PubMed ID: 31366401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
    Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
    BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.
    Lucas GM; Jing Y; Sulkowski M; Abraham AG; Estrella MM; Atta MG; Fine DM; Klein MB; Silverberg MJ; Gill MJ; Moore RD; Gebo KA; Sterling TR; Butt AA;
    J Infect Dis; 2013 Oct; 208(8):1240-9. PubMed ID: 23904290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study.
    Lee JJ; Lin MY; Yang YH; Lu SN; Chen HC; Hwang SJ
    Am J Kidney Dis; 2010 Jul; 56(1):23-31. PubMed ID: 20400217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney Function Decline in Patients with CKD and Untreated Hepatitis C Infection.
    Tartof SY; Hsu JW; Wei R; Rubenstein KB; Hu H; Arduino JM; Horberg M; Derose SF; Qian L; Rodriguez CV
    Clin J Am Soc Nephrol; 2018 Oct; 13(10):1471-1478. PubMed ID: 30242027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Hepatitis C and B Virus Infection with CKD and Impact of Hepatitis C Treatment on CKD.
    Zhang H; Xu H; Wu R; Yu G; Sun H; Lv J; Wang X; Chi X; Gao X; Kong F; Zhang M; Hang L; Jiang J; Pan Y; Niu J
    Sci Rep; 2019 Feb; 9(1):1910. PubMed ID: 30760762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More improvement than progression of liver fibrosis following antiretroviral therapy in a longitudinal cohort of HIV-infected patients with or without HBV and HCV co-infections.
    Ding Y; Duan S; Ye R; Yang Y; Yao S; Wang J; Cao D; Liu X; Lu L; Jia M; Wu Z; He N
    J Viral Hepat; 2017 May; 24(5):412-420. PubMed ID: 27925409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.
    Fabbri G; Mastrorosa I; Vergori A; Mazzotta V; Pinnetti C; Grisetti S; Zaccarelli M; Ammassari A; Antinori A
    BMC Infect Dis; 2017 Mar; 17(1):182. PubMed ID: 28249574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
    Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
    J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hepatitis virus infection on arterial calcification among incident hemodialysis patients.
    Fayed A; Soliman A; El Mahdy H; Hamza W; Abdulazim DO; Salem MM; Sharaf El Din UA;
    Nefrologia (Engl Ed); 2020; 40(3):336-344. PubMed ID: 31864861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients.
    Filippini P; Coppola N; Pisapia R; Martini S; Marrocco C; Di Martino F; Sagnelli C; Filippini A; Sagnelli E
    J Med Virol; 2007 Nov; 79(11):1679-85. PubMed ID: 17854026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease.
    Mederacke I; Meier M; Lüth JB; Schmidt-Gürtler H; Raupach R; Horn-Wichmann R; Wursthorn K; Potthoff A; Colucci G; Manns MP; Wedemeyer H; Tillmann HL
    Nephrol Dial Transplant; 2011 Aug; 26(8):2648-56. PubMed ID: 21273235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings.
    Dobseu R; Nanfack A; Kowo M; Ambada G; Kamgaing R; Chenwi C; Fainguem N; Ka'e A; Ngangoum E; Sosso S; Tchiegang C; Ndjolo A
    BMC Infect Dis; 2020 Oct; 20(1):758. PubMed ID: 33059627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: Systematic review and meta-analysis.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Med Virol; 2016 Mar; 88(3):487-97. PubMed ID: 26271205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.
    Kalayjian RC; Lau B; Mechekano RN; Crane HM; Rodriguez B; Salata RA; Krishnasami Z; Willig JH; Martin JN; Moore RD; Eron JJ; Kitahata MM
    AIDS; 2012 Sep; 26(15):1907-15. PubMed ID: 22824630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease.
    Lai TS; Lee MH; Yang HI; You SL; Lu SN; Wang LY; Yuan Y; L'Italien G; Chien KL; Chen CJ;
    Kidney Int; 2017 Sep; 92(3):703-709. PubMed ID: 28532708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.
    Crespo M; Navarro J; Moreno S; Sanz J; Márquez M; Zamora J; Ocampo A; Iribaren JA; Rivero A; Llibre JM
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):493-498. PubMed ID: 27061975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons.
    Mocroft A; Ryom L; Oprea C; Li Q; Rauch A; Boesecke C; Uzdaviniene V; Sedlacek D; Llibre JM; Lacombe K; Nielsen LN; Florence E; Aho I; Chkhartishvili N; Szlavik J; Dragovic G; Leen C; Sambatakou H; Staub T; Laguno M; Elinav H; Tomažič J; Peters L;
    AIDS; 2020 Aug; 34(10):1485-1495. PubMed ID: 32675562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.